Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

East Hanover, New Jersey 07936


Purpose:

This study will evaluate the safety, tolerability and efficacy of darifenacin, in the long-term treatment of adult patients with overactive bladder.


Criteria:

Inclusion Criteria: - Adult patients with overactive bladder who completed a previous darifenacin short-term trial. - Patients capable of independent toileting and able of independently completing the patient diary. Exclusion Criteria: - Patients in whom the use of anticholinergic drugs was contraindicated - Evidence of severe liver disease - Patients with other clinically significant urinary or gynecological conditions Other protocol-defined inclusion/exclusion criteria may apply.


NCT ID:

NCT00170755


Primary Contact:

Study Chair
Novartis
East Hanover NJ


Backup Contact:

N/A


Location Contact:

East Hanover, New Jersey 07936
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.